Although LTE4 has little activity at CysLT1 and CysLT2 receptors [37], inhalation of LTE4 increases airway inflammatory cells [58,59] and AHR in asthma patients [60], particularly in those with ASA [37]. This evidence concerns the gene CYSLTR1 and asthma.